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Introduction: Evidence from randomized controlled trials (RCTs) is required to guide treatment of critically ill
children, but the number of RCTs available is limited and the publications are often difficult to find. The objectives
of this review were to systematically identify RCTs in pediatric critical care and describe their methods and
reporting.
Methods: We searched MEDLINE, EMBASE, LILACS and CENTRAL (from inception to April 16, 2013) and reference
lists of included RCTs and relevant systematic reviews. We included published RCTs administering any intervention
to children in a pediatric ICU. We excluded trials conducted in neonatal ICUs, those enrolling exclusively preterm
infants, and individual patient crossover trials. Pairs of reviewers independently screened studies for eligibility,
assessed risk of bias, and abstracted data. Discrepancies were resolved by consensus.
Results: We included 248 RCTs: 45 (18%) were multicentered and 14 (6%) were multinational. Trials most frequently
enrolled both medical and surgical patients (43%) but postoperative cardiac surgery was the single largest population
studied (19%). The most frequently evaluated types of intervention were medications (63%), devices (11%) and nutrition
(8%). Laboratory or physiological measurements were the most frequent type of primary outcomes (18%). Half of
these trials (50%) reported blinding. Of the 107 (43%) trials that reported an a priori sample size, 34 (32%) were stopped
early. The median number of children randomized per trial was 49 and ranged from 6 to 4,947. The frequency of RCT
publications increased at a mean rate of 0.7 RCTs per year (P<0.001) from 1 to 20 trials per year.
Conclusions: This scoping review identified the available RCTs in pediatric critical care and made them accessible to
clinicians and researchers (epicc.mcmaster.ca). Most focused on medications and intermediate or surrogate outcomes,
were single-centered and were conducted in North America and Western Europe. The results of this review underscore
the need for trials with rigorous methodology, appropriate outcome measures, and improved quality of reporting to
ensure that high quality evidence exists to support clinical decision-making in this vulnerable population.Introduction
Evidence from randomized controlled trials (RCTs) is
required to guide treatment of critically ill children.
There are fewer RCTs in pediatrics when compared to
adult medicine; in reviews of RCTs published in general
and specialist medical journals only 14% of trials enrolled
exclusively children [1,2]. Moreover, while the methodo-
logical quality of pediatric RCTs appears to be improving,
37 to 59% were still at high risk of bias [3-5]. Finally, the
focus of published pediatric RCTs may not align with the
frequency or importance of the conditions seen in clinical* Correspondence: duffetmc@mcmaster.ca
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reproduction in any medium, provided the orpractice. For example, in pediatric primary care there
is discordance between the conditions studied and the
frequency seen in clinical practice: 23% of Cochrane
systematic reviews relevant to pediatrics focused on
asthma, which represents 3 to 5% of children’s primary
care visits [6].
The extent of these challenges in pediatric critical care
has not previously been examined. An example from critical
care is the Surviving Sepsis Campaign’s International
Guidelines for Management of Severe Sepsis and Septic
Shock [7]. These guidelines highlight the limited quality
of evidence available in pediatric critical care to support
clinical decision-making. The consensus committee was
able to make 76 recommendations for adults, but only 22
pediatric-specific recommendations. Not only are thereLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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evidence informing these pediatric recommendations is
lower; 3 (14%) of the pediatric recommendations were
supported by high/moderate evidence as compared to 41
(54%) of those for adults.
To effectively apply the results of pediatric critical care
RCTs, it is imperative that clinicians can easily and effi-
ciently find these publications. However, clinicians are not
typically trained to conduct the complex literature searches
required to find pediatric RCTs; even a highly specific
search strategy yielded only 56% of citations relevant to
children [8]. Challenges in locating relevant pediatric RCTs
are likely to increase as the number of adult RCTs
increases faster than the number of pediatric RCTs in both
general medical journals (4.7 RCTs per year vs. 0.4 RCTs
per year) and in specialist journals (91 RCTs per year vs.
17 RCTs per year) [1,2]. There also are few tools,
resources or reviews to help clinicians quickly access or
identify the available RCTs in pediatric critical care.
A scoping review systematically maps a broad and diverse
body of research evidence [9]. We conducted this scoping
review to systematically identify and describe RCTs in




We included RCTs and quasi-randomized trials that
reported the effect of any intervention on children or
their families in a pediatric intensive care unit. We used
the authors’ definitions of pediatric and only included
trials in which critically ill children were a subgroup if
the demographic and outcome data for the critically ill
children were reported separately. We considered a unit to
be an intensive or critical care unit if the authors described
it as such and if it had the capacity to provide mechanical
ventilation. We included trials in all languages. We ex-
cluded trials enrolling exclusively preterm infants or
infants in a neonatal intensive care unit, individual patient
crossover trials and those only published as abstracts. For
trials reported in multiple publications we used the most
recent publication. We excluded substudies and secondary
publications of included RCTs.
Searching
We searched MEDLINE, EMBASE, LILACS and CEN-
TRAL from inception to April 16, 2013. To identify RCTs
we used previously tested search strategies for MEDLINE
(the Cochrane Highly Sensitive Search Strategy, sensitivity-
and precision-maximizing version [10]) EMBASE [11] and
LILACS [12]. To identify studies enrolling children in
MEDLINE we used a previously tested strategy [8] and
adapted for the other databases. We then added search
terms related to pediatric critical care. Additional file 1:Appendix A contains the full search strategies (see
Additional file 1). To identify other potentially relevant
trials, we also examined the reference lists of all in-
cluded RCTs, systematic reviews identified by our
searches, and the researchers’ personal files.
Study selection and data extraction
We developed an electronic data collection tool using
DistillerSR™ (Evidence Partners Incorporated, Ottawa, ON,
Canada) and an accompanying screening and data extrac-
tion manual. To increase consistency among reviewers, all
reviewers screened the same 50 publications, discussed the
results and amended the screening and data extraction
manual before beginning screening for this review. Nine
reviewers working in pairs sequentially evaluated the titles,
abstracts and then full text of all publications identified
by our searches for potentially relevant publications.
Reviewers then worked in pairs to independently and
in duplicate extract data from the included trials using a
pretested electronic data collection tool. We recruited
other individuals with a clinical or research methodology
background to screen and extract data from non-English
trials. We were not able to complete duplicate data extrac-
tion for two trials because of the language of publication.
We resolved disagreements on study selection and data
extraction by consensus and discussion with other re-
viewers if needed. We extracted data from the main trial
publication and also any referenced published protocols
and supplemental materials.
Risk of bias assessment
We used the Cochrane Risk of Bias Tool to describe the
risk of bias for the included trials [13]. This tool rates
each trial as low, unclear, or high risk of bias for each of the
following factors: sequence generation, allocation conceal-
ment, blinding of participants and personnel, blinding of
outcome assessment, incomplete outcome data, selective
outcome reporting, and other sources of bias. We then
classified the overall risk of bias for each trial as low (low
risk of bias in all domains), high (high risk of bias in at
least one domain), or unclear.
Statistical analysis
We used the kappa statistic to assess agreement between
reviewers and considered values of 0.6 or greater to indicate
substantial agreement [14]. In summarizing the characteris-
tics of included systematic reviews and RCTs we reported
continuous data as medians (interquartile range (IQR), and
binary data as count (percent). We used linear regression
to evaluate the changes over time in the number of trials
published. We used the Mann-Whitney U test to compare
the number of children randomized in trials that reported
early stopping and those that did not and those that
reported funding and those that did not, hypothesizing
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We used Fisher’s exact test to compare the proportion
of trials that were stopped early among those reporting
funding with those that did not, hypothesizing that
funded trials would be less frequently stopped early. We
used alpha = 0.05 as the criterion for statistical significance.
We used SPSS Statistics Version 21 (IBM Corp. Armonk,
NY, USA) to perform the statistical analysis.
Results
Trial publication
We included 248 RCTs randomizing a total of 27,013
children out of 7,771 unique publications screened.
Figure 1 shows the flow of studies through the review
process and Additional file 2: Appendix B lists all of
the included trials (see Additional file 2). Chance-
corrected agreement for study inclusion was almost per-
fect (kappa = 0.93, 95% CI 0.91 to 0.96). The included
RCTs were published in 89 different journals. The five
journals that published the highest number of trials:
Pediatric Critical Care Medicine (31), Critical Care
Medicine (29), Intensive Care Medicine (19), Journal ofFigure 1 Review flow diagram. aOne publication included two
related RCTs: a single-center and a multicenter trial with different in-
clusion and exclusion criteria. RCTs, randomized controlled trials; SR,
systematic review; PICU, pediatric intensive care unit; NICU, neonatal
intensive care unit.Pediatrics (7) and The New England Journal of Medicine (7)
published 32% of the included trials. Almost half (46%)
were published in the 17 journals with a specific critical
care focus. Sixteen trials (6%) were published in six lan-
guages other than English. Figure 2 shows the number of
trials published per year. The number of trials published
per year increased from one in 1986 to twenty in 2012.
The mean rate of increase was 0.7 RCTs per year (95%
CI = 0.5 to 0.8; P <0.001; r2 = 0.76).
Description of included trials
Table 1 shows the characteristics of included trials. The
majority (82%), were single-centered and the median (IQR)
number of centers participating in the multicentered trials
was five (two to eight) and varied from two to one hundred
and four. Trials were conducted in 31 different countries
(Figure 3). The majority, 170 (69%), were from North
America (104 trials) or Western Europe (66 trials) and
were concentrated in a small number of countries. With
respect to the number of trials conducted, the top five
countries (Brazil, Canada, India, The Netherlands and
the United States) conducted 59% of the RCTs. When
measured by the number of children randomized, the
top five countries (Australia, Brazil, Canada, Germany, and
the United States) enrolled 69% of the children randomized.
The countries with the highest median number of children
randomized per trial were Argentina (149), Spain (122),
Israel (107) and The Netherlands (74).
All trials randomized individual children except one
cluster RCT which randomized ten PICUs in five centers
[15]. Approximately half (54%) of the 183 trials that
reported the duration of enrolment were completed in less
than two years. Thirty-eight trials (15%) reported in the
publication that the trial had been registered. A significant
proportion of trials (41%) did not report their funding
source and 16% had at least some industry funding.
Table 2 shows the populations studied. Families were



















Year of Publication  
Figure 2 Number of pediatric critical care randomized
controlled trials published per year (1986 to 2012). An
additional 12 trials were published between January and April 2013.
Table 1 Methodological characteristics of 248 pediatric
critical care trials (1986 to 2013)
Characteristics RCTs n (%)
Multicentered 45 (18)
Multinational 14 (6)
Number of children randomized 49 (30 to 93)a
Min 6, Max 1199b
Number of children included in analysis 44 (28 to 80)a
Min 6, Max 980b
Type of primary outcome
Laboratory or physiological 44 (18)
Clinical complications 29 (12)
Duration of ventilation 14 (6)
Severity of illness score 14 (6)
Clinical success 13 (5)
Process of care 13 (5)
Mortality 5 (2)
Other 32 (13)
Not reported 82 (33)
Source of funding
Noncommercial only 102 (41)
Commercial only 28 (11)
Both commercial and noncommercial 12 (5)
None 5 (2)
Not reported 101 (41)









aMedian (IQR, interquartile range); bthis maximum does not include the one
cluster RCT that randomized ten PICUs at five sites and included 4,947
children [15].
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pants in the 150 of 248 trials (61%) in which the mean
age was reported was 4.2 years (minimum 1 month,
maximum 14 years). Medical and surgical patients were
similarly represented (23% and 24% respectively) with
cardiac surgery patients representing the commonest
group of patients studied (19%). Table 3 shows the types
of conditions studied. Respiratory conditions were the
most commonly studied (24%), followed by cardiac (16%)
and gastrointestinal (15%) conditions. The majority of
trials evaluated medications (Table 4) with analgesics
and sedatives being the most frequent group of drugs
evaluated (8%).We could determine the primary outcome in 166 (67%)
trials (Table 1). Of these, laboratory and physiological
primary outcomes were the most frequently reported.
Mortality was the primary outcome measure in only 2%
of trials. Of the 148 trials (60%) reporting mortality, the
median (IQR) mortality was 8% (1 to 15%), varying from
0% to 94%. The mortality was 0% in 33 trials (13%). We
could assess the statistical significance of the primary
outcome (using the authors definitions or P <0.05 if not
defined) in 133 RCTs that compared two interventions.
In 67 (50%) of trials, the results were statistically significant:
62 (93%) of these favored the experimental intervention.Sample size
The number of children randomized in individual-patient
RCTs varied from 6 to 1,199; the one cluster RCT random-
ized 10 PICUs and included 4,937 children. There were
six trials randomizing more than 500 (including three
randomizing more than 1,000) children, all published since
2001. The median (IQR) number of children randomized
per trial was 49 (30 to 93). The median sample sizes varied
from 23 to 98 in the period 1986 to 2013 and was less than
50 for 16 of these 28 years of publication (Figure 4). The
number of children randomized per year increased from 40
in 1986 to 3,806 in 2012. The mean rate of increase was 82
children per year (95% CI = 49 to 115; P <0.001; r2 = 0.49).
A total of 134 trials (54%) included all randomized children
in the analysis. The median (IQR) number of children ran-
domized in the 142 RCTs that reported a funding source
compared to trials that did not was not significantly differ-
ent: 44 (80 to 32) compared to 52 (30 to 100), P = 0.24.
We also evaluated the completeness of follow-up and
early stopping among these RCTs. The mean proportion
of randomized children who were not included in the ana-
lysis was 6% and varied from 0 to 59%. Thirty-four trials
(15% of all 248 trials) were stopped early, most frequently
for futility or recruitment problems (Table 1). Of the 107
trials that reported a planned sample size, 32% were
stopped early. A total of 17% of the 142 trials reporting
any funding were stopped early, compared to 8% of those
who did not report funding (P = 0.04). The median (IQR)
number of children randomized in trials that were stopped
early was 50 (26 to 134) and 49 (30 to 84) in those that
were not reported to be stopped early (P = 0.71).Risk of bias
Figure 5 presents the risk of bias assessments for the
individual domains of the Cochrane Risk of Bias tool.
The overall risk of bias was low for 11 (4%) trials, high
for 108 (44%) and unclear for the remaining 129 (44%).
All trials at low risk of bias were published since 2006.
Blinding was only reported in half the trials (125/248).
Nine (6%) trials were quasi-randomized trials: using a
Figure 3 Number of published pediatric critical care randomized controlled trials per country (1986 to 2013). This map shows the
country where each trial was conducted. We used the country of the primary author for multinational trials.
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participants to treatment groups.
Discussion
Scoping reviews can be used ‘to examine the extent,
range, and nature of research activity; to determine the
value for undertaking a full systematic review; to summarize
and disseminate research findings; and to identify research
gaps in the existing literature’ [16]. In this scoping review
we found 248 pediatric critical care RCTs, from 31 coun-
tries, published in 7 languages over 28 years. The majority
of these RCTs were single-centered, focused on intermedi-
ate or surrogate outcomes and were small in sample size.
Important aspects of their methodology and reporting
remain less than optimal. As part of this review we have
created a publicly accessible online database of these trialsTable 2 Categories of patients enrolled in 248 pediatric
critical care trials (1986 to 2013)
Patient type RCTs n (%)
Medical/Surgical 106 (43)




Other medical 19 (8)
Surgical only 60 (24)
Cardiac surgery 46 (19)
Noncardiac surgery 14 (6)
Trauma/Burns only 26 (10)
Traumatic brain Injury 13 (5)
Burns 13 (5)including key methodological features and links to the
original reports [17].
There are gaps in the body of pediatric critical care
RCT research. For example, rehabilitation and the needs
of parents coping with their child’s illness are relevant
for almost all critically ill children, yet there are only two
trials focusing on each of these. Similarly, pharmacological
interventions were studied in the majority of RCTs;
although 27% of RCTs studied devices, there were no trials
focused on renal replacement therapy or extracorporal
membrane oxygenation. Pediatric critical care clinicians,
researchers and decision-makers can use the results of this
review as part of a process to evaluate unmet needs and
set research priorities, both in terms of the focus and
design of additional RCTs and other research designs.
There are also important limitations to the reporting of
these trials; for example, only two-thirds reported the
primary outcome and less than half reported the planned
sample size or the funding source.
When compared to the findings of a random sample
of 300 pediatric RCTs published in 2007, pediatric critical
care RCTs were less frequently multicentered (18% vs.
35%), randomized fewer children (median 49 vs. 83), and
had a lower proportion assessed as having a low risk of
bias (4% vs. 8%) [5]. Pediatric critical care RCTs are also
smaller and less common than adult critical care RCTs. A
systematic review of adult critical care RCTs with clinical
or economic primary outcomes published in 16 prominent
journals included 127 RCTs published between 2007 and
2012 [18]. We identified 79 pediatric RCTs over the same
time period. Compared to these adult RCTs, pediatric RCTs
randomized fewer participants (mean 109 vs. 519), and
were less frequently multicentered (18% vs. 60%). An-
other systematic review of RCTs evaluating nutritional
Table 3 Types of conditions studied in 248 pediatric
critical care trials (1986 to 2013)
Indication RCTs n (%)
Respiratory 59 (24)
ARDS/ALI 14 (6)
Post extubation stridor 11 (4)









Stress ulcer prophylaxis 8 (3)
Feeding tube placement 5 (2)
Other 2 (1)
Infection 33 (9)













ARD, acute respiratory distress syndrome; ALI, acute lung injury.
Table 4 Types of interventions studied in 248 pediatric
critical care trials (1986 to 2013)






Medical gases 11 (4)
Surfactants 8 (3)








IV catheters, care or placement 7 (3)
Feeding tube placement 6 (2)
Ventilator or other respiratory 5 (2)




IV fluids 14 (6)





More than one type of intervention 21 (9)
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randomizing a mean of 112 adults in the period 1980 to
2008 [19]. Using similar criteria, we found 17 trials ran-
domizing a mean of 48 children in the same time period.
We found that pediatric RCTs are generally small,
single-centered, and primarily measured short-term
laboratory and physiological outcomes. This raises two
important issues for clinicians, researchers and funding
agencies to consider. The first question is whether or
not the small sample size matters: were these studies
able to definitively answer the question posed? This is
unclear for many trials included in this review as 57%
did not report the planned sample size. The second
question is did these trials use appropriate outcome
measures? Trials focusing on surrogate or intermediate
outcomes can be used to inform the design and conduct offuture studies using patient-important outcomes or when a
trial with patient-important outcomes is not feasible [20].
Further research should focus on assessing if these RCTs
lead to subsequent trials focusing on patient-important
outcomes or if the outcomes used are indeed appropriate
surrogates for more patient-important outcomes [21]. If
many trials are indeed too small to generate clear results,
further research needs to be done to identify the barriers
to conducting larger trials and methods to overcome this
limitation. A previous mixed-methods study of pediatric
trialists identified a lack of research training, negative
research culture and logistical challenges as barriers to
conducting methodologically rigorous pediatric RCTs [22].
One important factor we identified is certainly feasibility,
as 27 trials in this review (11% of all trials, 22% of those
reporting an a priori sample size) were stopped early for
























Figure 4 Number of children randomized in 236 pediatric
critical care randomized controlled trials (1986 to 2012). The
center of each box indicates the median number of children
randomized in the RCTs published in each year. The bottom and top
of each box indicate the 1st and 3rd quartile respectively and the
whiskers indicate the maximum and minimum values for RCTs in
that year. An additional 12 trials published between January and
April 2013.
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identify relevant trials and incorporation of trials published
in any language. For each study we assessed the clinical
and methodological features, and the completeness and
transparency of reporting. We have also made publicly
available data from the included trials and links to the
full-text publications [17]. This is updated quarterly. The
public availability of the results of this scoping review
increases the ability of clinicians and pediatric critical care
researchers to easily access pre-appraised, relevant RCTs.
Finally, by synthesizing the methodological features of,
and identifying gaps in, the body of pediatric critical care
research, it will allow researchers and funding agencies to
prioritize trial designs to fill the gaps we identify in the
conditions studied, trial methods, interventions, and the
outcomes assessed.0% 25%
Random sequence generation 
Allocation concealment 
Blinding: participants & personnel 
Blinding: outcome assessment 
Incomplete outcome data 
Selective reporting 
Other bias 
Low risk of 
Figure 5 Risk of bias in 248 pediatric critical care randomized control
describe the risk of bias for the included trials.This scoping review has some limitations. The relevance
of this review to clinicians in some resource-limited
areas may be limited, as a priori, we excluded trials
that were conducted in settings where mechanical ven-
tilation was not available. We limited this review to
RCTs conducted in a pediatric ICU and acknowledge
that that some trials conducted in other populations
such as critically ill adults or neonates, or in other
settings such as prehospital, the emergency department,
or the operating room may also inform the care of chil-
dren in the ICU. Our objective in this review was to
identify and describe pediatric critical care RCTs. Other
research designs are also relevant to pediatric critical
care practice, but are beyond the scope of a single review
to include all the potentially relevant research. To focus
on trials most likely to inform clinical practice and to
improve the feasibility of this review we also excluded
individual patient crossover trials.Conclusions
This pediatric critical care scoping review identified the
available RCTs and made them accessible to clinicians
and researchers. Most RCTs focused on medications and
intermediate or surrogate outcomes, were single-centered
and were conducted in North America and Western
Europe. While the number of published trials is increasing
over time, the sample size is not. The results of this review
underscore the need for trials with rigorous methodology,
appropriate outcome measures, and improved quality
of reporting in pediatric critical care. Such trials on a
broad range of topics relevant to pediatric critical illness
are required to ensure that more rigorous evidence exists
to support clinical decision-making in this vulnerable
population. 50% 75% 100% 
bias Unclear risk of bias High risk of bias 
led trials (1986 to 2013). We used the Cochrane Risk of Bias Tool to
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 This scoping review identified the available RCTs in
pediatric critical care and made them accessible to
clinicians and researchers (epicc.mcmaster.ca).
 Most RCTs focused on medications and
intermediate or surrogate outcomes, were
single-centered and were conducted in North America
and Western Europe.
 While the number of published trials is increasing
over time, the sample size is not.
 The results of this review underscore the need for
trials with rigorous methodology, appropriate
outcome measures, and improved quality of
reporting.
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